COVID-19 vaccines: challenges and solutions

被引：5

作者：

Mohseni Afshar, Zeinab ^{[1
]}

Babazadeh, Arefeh ^{[2
]}

Janbakhsh, Alireza ^{[1
]}

Afsharian, Mandana ^{[1
]}

Ebrahimpour, Soheil ^{[2
]}

机构：

[1] Kermanshah Univ Med Sci, Imam Reza Hosp, Clin Res Dev Ctr, Kermanshah, Iran

[2] Babol Univ Med Sci, Infect Dis & Trop Med Res Ctr, Hlth Res Inst, Babol, Iran

来源：

MINERVA RESPIRATORY MEDICINE | 2021年 / 60卷 / 04期

关键词：

SARS-CoV-2; COVID-19; Vaccines; DISEASE; 2019; COVID-19; NEED;

D O I：

10.23736/S2784-8477.21.01921-0

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a global emergency by the World Health Organization (WHO). Several ways have been used to control and manage the COVID-19 pandemic. Among them, development of vaccines could be an important breakthrough against novel virus. It is important to note that the candidate vaccine is expected to work against infection and transmission. To date, many COVID-19 vaccine clinical trials have been registered worldwide. However, some vaccine candidates could meet adequate standards for effectiveness and safety. In the current review, we discussed the effectiveness, safety, target population, and hesitancy of COVID-19 vaccines.

引用

页码：136 / 141

页数：6

共 37 条

[1] Vital role of chest CT in diagnosis of coronavirus disease 2019 (COVID-19) [J].

Afshar, Zeinab Mohseni ;

Ebrahimpour, Soheil ;

Javanian, Mostafa ;

Vasigala, VeneelaKrishna Rekha ;

Masrour-Roudsari, Jila ;

Babazadeh, Arefeh .

CASPIAN JOURNAL OF INTERNAL MEDICINE, 2020, 11 (03) :244-249

[2] Coronavirus disease 2019 (COVID-19), MERS and SARS: Similarity and difference [J].

Afshar, Zeinab Mohseni ;

Ebrahimpour, Soheil ;

Javanian, Mostafa ;

Koppolu, Veerendra ;

Vasigala, Veneela Krishna Rekha ;

Hasanpour, Amir Hossein ;

Babazadeh, Arefeh .

JOURNAL OF ACUTE DISEASE, 2020, 9 (05) :194-199

[3] The Russian vaccine for COVID-19 [J].

Burki, Talha Khan .

LANCET RESPIRATORY MEDICINE, 2020, 8 (11) :E85-E86

[4]

Castells MC, 2021, NEW ENGL J MED, V384, P643, DOI [10.1056/NEJMra2035343, 10.1056/NEJMc2100766]

[5] Optimizing safety surveillance for COVID-19 vaccines [J].

Chandler, Rebecca E. .

NATURE REVIEWS IMMUNOLOGY, 2020, 20 (08) :451-452

[6] Considering Emotion in COVID-19 Vaccine Communication: Addressing Vaccine Hesitancy and Fostering Vaccine Confidence [J].

Chou, Wen-Ying Sylvia ;

Budenz, Alexandra .

HEALTH COMMUNICATION, 2020, 35 (14) :1718-1722

[7] A strategic approach to COVID-19 vaccine R&D [J].

Corey, Lawrence ;

Mascola, John R. ;

Fauci, Anthony S. ;

Collins, Francis S. .

SCIENCE, 2020, 368 (6494) :948-950

[8] Coronavirus disease 2019 vaccines in pregnancy [J].

Craig, Amanda M. ;

Hughes, Brenna L. ;

Swamy, Geeta K. .

AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM, 2021, 3 (02)

[9] Vaccine Safety, Efficacy, and Trust Take Time [J].

Dermody, Terence S. ;

DiMaio, Daniel ;

Enquist, Lynn W. .

ANNUAL REVIEW OF VIROLOGY, VOL 8, 2021, 8 :III-V

[10] Vaccine hesitancy: the next challenge in the fight against COVID-19 [J].

Dror, Amiel A. ;

Eisenbach, Netanel ;

Taiber, Shahar ;

Morozov, Nicole G. ;

Mizrachi, Matti ;

Zigron, Asaf ;

Srouji, Samer ;

Sela, Eyal .

EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2020, 35 (08) :775-779

← 1 2 3 4 →